Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04023565
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Sergey V. Nedogoda
- Registry
-
NCT04023565
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT04023565. Allocation not applicable; no masking; primary purpose treatment. Start 2019-03-11 (actual); primary completion 2020-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
- Acronym
- COMPOSER
- Condition
- Arterial Hypertension
- Condition
- Metabolic Syndrome
- Intervention (Drug)
- perindopril + moxonidine
- Lead sponsor
- Sergey V. Nedogoda
Record details
- Record id
cardio:ct-nct04023565- Content hash
48fc84434e68a8fa266ebe5e8323bb28f6df849d1f33516f4592914b2ce36bab